Johannes CB, Chiang CC, Ng EW, Eng PM, Seeger JD, Walker AM. Treatment patterns in patients using biological disease modifying antirheumatic therapy for rheumatoid arthritis. Presented at the 21st International Conference on Pharmacoepidemiology; August 2005. Nashville, TN. [abstract] Pharmacoepidemiol Drug Saf. 2005 Sep; 14(Suppl 2):S195. doi: 10.1002/pds.1136
Arellano FA, Wentworth CE, May C, Verma A, Rivero E, Rothman KJ. Use of prescription Cyclo-Oxygenase 2 Inhibitors (COX-2) and non COX-2 Non-Steroidal Anti-Inflammatory Drugs (NSAID) in a UK population. Poster presented at the 21st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; June 2005. Nashville, TN. [abstract] Pharmacoepidemiol Drug Saf. 2005 Sep; 14(Suppl S2):S141. doi: 10.1002/pds.1136
Mines DI, Novelli LA, Yu H. Lymphoma risk in patients with rheumatoid arthritis who received 2 or more disease modifying anti-rheumatic drugs (DMARDs): a retrospective cohort study in the GPRD. Poster presented at the 21st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2005. Nashville, TN. [abstract] Pharmacoepidemiol Drug Saf. 2005 Aug; 14(S2):S30.
Gutierrez LP, Maguire A, Mattsson A, Wilton P. Incidence of malignant neoplasm in children treated with recombinant growth hormone: the KIGS registry experience 1987-1994. Poster presented at the 21st International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2005. Nashville, TN. [abstract] Pharmacoepidemiol Drug Saf. 2005 Aug; 14(S1):S330.
Cole JA, Johannes CB, Loughlin J, Seeger JD, Velentgas P, Walker AM. Challenges in conducting propensity score matched cohort studies. Presented at the 21st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2005. Nashville, TN. [abstract] Pharmacoepidemiol Drug Saf. 2005 Aug; 14(Suppl 2):S175.
Oliveria SA, Johannes CB, Simon TA, Saunders WB, Stang PE. Estimating off label drug use in two pediatric populations using claims data. Poster presented at the 21st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2005. Nashville, TN. [abstract] Pharmacoepidemiol Drug Saf. 2005 Aug; 14(S 2):S47.
Eng PM, Johannes CB, Chaing CC, West WA, Seeger JD. Survey of disability, medication use, and medication satisfaction among members with rheumatoid arthritis of a large health care plan database. Poster presented at the 21st International Conference on Pharmacoepidemiology; August 2005. Nashville, TN. [abstract] Pharmacoepidemiol Drug Saf. 2005 Aug; 14(Suppl 2):S5.
Arellano FA, Wentworth CE, May C, Verma A, Rivero E, Rothman KJ. Use of prescription cyclo-oxigenase 2 inhibitors (COX-2) and non cox-2 non-steroidal anti-inflammatory drugs (NSAIDS) in a UK population. Pharmacoepidemiol Drug Saf. 2005 Jul;14(Suppl 1):S141.
Mines D, Hill D, Yu H, Novelli L. Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram. Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):367-72.
Perez-Gutthann S. ISPE Commentary: twentieth annual conference on pharmacoepidemiology and therapeutic risk management. 2005.